 |
|
 |
|
 |
| |
| This satellite workshop organized from the 2D-BioPAD project, hosted by the organizers of the NanoBalkan Conference 2025, will explore how atomically thin materials —such as graphene, transition-metal dichalcogenides, MXenes and others—, and other low dimensional materials, unlock new possibilities in neuroscience and biomedicine. We will invite speakers from industry and academia to dissect new trends in the field, and chemists, physicists, and engineers to discuss about implantable electrodes, biosensors and precision drug nanocarriers. Embedded in the NanoBalkan Conference 2025, presenters and attendees will benefit from networking events and discussions during the whole NanoBalkan Conference |
| |
| DATE: October 01, 2025 |
|
| Chairperson: Makis Angelakeris |
| |
| Tentative Program - More info |
|
| |
|
|
| | |
 |
|
Makis Angelakeris |
Aristotle University of Thessaloniki |
Greece |
|
|
|
 |
|
Stefano Casalini |
University of Padua |
Italy |
|
|
 |
|
Fatouros Dimitrios |
Aristotle University of Thessaloniki |
Greece |
|
|
 |
|
Danilo Echeverri |
ICN2 |
Spain |
|
|
|
 |
|
Sandeep Kumar |
NOVAPTECH |
France |
|
|
|
 |
|
Alessandro Silvestri |
Università Ca' Foscari Venezia
|
Italy |
|
|
|
| |
|
|
|
| Workshop on Low-dimensional materials for Neuroscience and Biomedicine
|
|
|
Makis Angelakeris (Aristotle University of Thessaloniki, Greece)
|
|
|
Magnetic nanoparticles as biosensing boosters
|
|
|
Stefano Casalini (University of Padua, Italy)
|
|
|
Water-dispersible graphenes for (bio-)sensing application
|
|
|
Fatouros Dimitrios (Aristotle University of Thessaloniki, Greece)
|
|
|
Engineering 3D-Printed Microneedles for Transdermal Delivery in Alzheimer’s Disease
|
|
|
Danilo Echeverri (ICN2, Spain)
|
|
|
Nanostructured Capacitive Biosensing Platforms for Clinical Diagnostics
|
|
|
Sandeep Kumar (NOVAPTECH, France)
|
|
|
The Aptamer advantage: Biosensing Solu7ons for Neurohealth and Environment
|
|
|
Alessandro Silvestri (Università Ca' Foscari Venezia
, Italy)
|
|
|
Electrochemical Sensors for the detection of neurotransmitters: from plasma to in-vitro neurodegenerative models
|
|
|
|
|
|
|
